Ascendant Resources Announces High Grade Copper Assay Results Supporting High-Grade Copper Corridor at the Venda Nova South Zone

Investing News NetworkYour trusted source for investing success

endpoints 2023

Biotech Investing
Biotech Investing

Medicenna Receives Amendment to Revamp Clinical Trial

Pharmaceutical Investing

Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

Pharmaceutical Investing

Auris Medical Receives Positive Scientific Advice from EMA on Development Plan and Regulatory Pathway for AM-111

Biotech Investing
Biotech Investing

Notes from the Floor: Bloom Burton & Co., Day 1

Biotech Investing
Biotech Investing

Shire Receives FDA Approval for Rare Disease Drug, Share Price Rises

Genetics Investing

Celldex’s METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint

Biotech Investing

Epizyme Announces Publication of Tazemetostat Phase 1 Clinical Data in The Lancet Oncology

Company News

Black Box Introduces Emerald Unified KVM Platform

Longevity Investing

Evolus Phase III European – Canadian Head-to-Head Trial of prabotulinumtoxinA Compared to Botox® Meets Primary Endpoint

Pharmaceutical Investing

Enrollment Completed in ADRESU Clinical Trial of Cytori Cell Therapy for Stress Urinary Incontinence

Pharmaceutical Investing

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554

MARKETS

Markets
TSX20758.34+17.90
TSXV620.09-10.59
DOW33926.01-127.93
S&P 5004136.48-43.28
NASD12006.95-193.86
ASX7558.10+46.50

COMMODITIES

Commodities
Gold1865.94+0.55
Silver22.35+0.01
Copper4.03-0.06
Palladium1713.170.00
Platinum1087.260.00
Oil73.23-2.65
Heating Oil2.79-0.11
Natural Gas2.38-0.07

DOWNLOAD FREE REPORTS

NEW! 2023 Gold Outlook: Australia Edition

NEW! 2023 Precious Metals Outlook: Australia Edition

NEW! 2023 Critical Metals Outlook.

NEW! 2023 Agriculture Outlook Report

NEW! 2023 Rare Earths Outlook: Australia Edition

Browse more resource reports ≫

NEW! 2023 Tech Outlook Report

NEW! 2023 Cleantech Outlook Report

Emerging Tech Outlook 2023

NEW! 2023 AI Outlook Report

NEW! 2023 Crypto Outlook Report

Browse more technology reports ≫

NEW! 2023 Pharmaceuticals Outlook Report.

FREE 2023 Psychedelics Investor Report

NEW! 2023 Biotech Outlook Report.

NEW! 2023 Life Science Outlook Report.

Start Here – Investing in Pharma

Browse more life science reports ≫

BROWSE COMPANIES BY SECTOR

loader